VERALTO CORPORATION Research and Development Expense
VERALTO CORPORATION (VLTO) reported Research and Development Expense of $68.00 million for the 3-month period ending 2026-04-03, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-29
- VERALTO CORPORATION research and development expense for the quarter ending 2026-04-03 was $68.00M, a 6.25% increase year-over-year.
- VERALTO CORPORATION research and development expense for the quarter ending 2025-12-31 was $68.00M, a 1.45% decline year-over-year.
- VERALTO CORPORATION research and development expense for the quarter ending 2025-10-03 was $67.00M, a 6.35% increase year-over-year.
- VERALTO CORPORATION research and development expense for the quarter ending 2025-07-04 was $67.00M, a 9.84% increase year-over-year.
- VERALTO CORPORATION research and development expense for fiscal 2025 was $266.00M, a 5.14% increase from fiscal 2024.
- VERALTO CORPORATION research and development expense for fiscal 2024 was $253.00M, a 12.44% increase from fiscal 2023.
- VERALTO CORPORATION research and development expense for fiscal 2023 was $225.00M, a 3.69% increase from fiscal 2022.
- VERALTO CORPORATION research and development expense for fiscal 2022 was $217.00M, a 11.07% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-04-03 | $68.00M 10-Q · filed 2026-04-29 | $136.00M derived: sum of 2 quarters · filed 2026-04-29 | $203.00M derived: sum of 3 quarters · filed 2026-04-29 | $270.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $135.00M derived: sum of 2 quarters · filed 2026-02-20 | $202.00M derived: sum of 3 quarters · filed 2026-02-20 | $266.00M 10-K · filed 2026-02-20 |
| 2025-10-03 | $67.00M 10-Q · filed 2025-10-29 | $134.00M derived: sum of 2 quarters · filed 2025-10-29 | $198.00M 10-Q · filed 2025-10-29 | $267.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-07-04 | $67.00M 10-Q · filed 2025-07-28 | $131.00M 10-Q · filed 2025-07-28 | $200.00M derived: sum of 3 quarters · filed 2026-04-29 | $263.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-04-04 | $64.00M 10-Q · filed 2026-04-29 | $133.00M derived: sum of 2 quarters · filed 2026-04-29 | $196.00M derived: sum of 3 quarters · filed 2026-04-29 | $257.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $132.00M derived: sum of 2 quarters · filed 2026-02-20 | $193.00M derived: sum of 3 quarters · filed 2026-02-20 | $253.00M 10-K · filed 2026-02-20 |
| 2024-09-27 | $63.00M 10-Q · filed 2025-10-29 | $124.00M derived: sum of 2 quarters · filed 2025-10-29 | $184.00M 10-Q · filed 2025-10-29 | $241.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-28 | $61.00M 10-Q · filed 2025-07-28 | $121.00M 10-Q · filed 2025-07-28 | $178.00M derived: sum of 3 quarters · filed 2026-02-20 | $233.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-29 | $60.00M 10-Q · filed 2025-04-30 | $117.00M derived: sum of 2 quarters · filed 2026-02-20 | $172.00M derived: sum of 3 quarters · filed 2026-02-20 | $229.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $57.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $112.00M derived: sum of 2 quarters · filed 2026-02-20 | $169.00M derived: sum of 3 quarters · filed 2026-02-20 | $225.00M 10-K · filed 2026-02-20 |
| 2023-09-29 | $55.00M 10-Q · filed 2024-10-24 | $112.00M derived: sum of 2 quarters · filed 2024-10-24 | $168.00M 10-Q · filed 2024-10-24 | $221.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $57.00M 10-Q · filed 2024-07-26 | $113.00M 10-Q · filed 2024-07-26 | $166.00M derived: sum of 3 quarters · filed 2025-02-25 | $218.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $56.00M 10-Q · filed 2024-04-24 | $109.00M derived: sum of 2 quarters · filed 2025-02-25 | $161.00M derived: sum of 3 quarters · filed 2025-02-25 | |
| 2022-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $105.00M derived: sum of 2 quarters · filed 2025-02-25 | $217.00M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $52.00M 10-Q · filed 2023-10-26 | $164.00M 10-Q · filed 2023-10-26 | ||
| 2021-12-31 | $244.00M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ITRON, INC. (ITRI) | United States | $4.008B | 13.83 |
| AEHR TEST SYSTEMS (AEHR) | United States | $3.176B | -420.65 |
| COHU INC (COHU) | United States | $3.015B | -82.78 |
| ALLIENT INC (ALNT) | United States | $1.913B | 61.10 |
| FREQUENCY ELECTRONICS INC (FEIM) | United States | $0.952B | 236.51 |
| TRANSCAT INC (TRNS) | United States | $0.805B | 250.33 |
| INTEST CORP (INTT) | United States | $0.146B | 291.94 |
| ScanTech AI Systems Inc. (STAI) | United States | $0.069B | -2.69 |
| DATA I/O CORP (DAIO) | United States | $0.030B | -4.65 |
| TERADYNE, INC (TER) | United States | $60.595B | 59.25 |